News

Pandemic Preparedness — Asep Inc. supports World Sepsis Day (September 13th) and announces the development of a test kit to identify severe sepsis, the leading cause of death and morbidity in pandemics

Asep Medical Inc. Announces Appointment of Dr. Robert E. W. Hancock as CEO and Chairman

Asep Medical Holdings Inc. Receives Revocation of Cease Trade Order from the BC Securities Commission.

Asep Medical Holdings Inc. Taking Actions for Revocation of Cease Trade Order

Asep Medical Holdings Inc. Announces Additional Listing to the OTCQB Venture Market in the U.S.

Asep Medical Holdings Inc. Announces Compelling Results of an Independent Sepsis Study Prepared by RTI Health Solutions

Asep Medical Holdings Inc. to Hold Online Investor Information Webinar on March 3, 2022

Asep Medical Inc. Announces its Antibiofilm/Anti-inflammatory Peptide Technology is in Advanced Development for Wound Dressings with US Army Funding1

Asep Medical Holdings Inc. Announces an Exclusive Licensing Arrangement for a Patented and Novel AI-Driven Sepsis Diagnosis Technology Developed at the University of British Columbia (UBC)

ASEP Medical Holdings Inc. Announces Additions to its Advisory Board, IR Team, and Digital Marketing Programs

ASEP Medical Holdings Inc. Announces Public Listing on Case to Drive Fight Against Antibiotic Failure